Company: LIMN
Filing Date: 2025-02-07
Form Type: 424B3
Source: 0001104659-25-010605
Chunk: 450

Company: Liminatus Pharma, Inc.
Filing Date: 2025-02-07
Form: 424B3
Chunk 450
---
,000,000.

F-25

TABLE OF CONTENTS

### IRIS ACQUISITION CORP

### NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS
On December 2, 2024 and January 7, 2025, the Company obtained additional advances under the Liminatus unsecured promissory note in the total amount of $500,000 which resulted in a total outstanding principal balance of $3,918,500.

The Loan was settled and deemed paid in full on December 29, 2024.

On December 20, 2024, in connection with the Special Meeting, stockholders holding 64,453 public shares properly exercised their right to redeem their shares at a redemption price of approximately $11.47 per share (subject to adjustment for taxes payable from the trust account), for an aggregate redemption amount of approximately $739,195. The redemptions were paid on January 7, 2025.

On December 26, 2024, the parties to the Business Combination Agreement amended the Business Combination Agreement to extend the date by which the Business Combination Agreement can be terminated in the event the business combination has not been consummated to June 30, 2025.

On December 26, 2024, the parties to the PIPE Equity Subscription Agreement entered into an amendment to such agreement to extend the termination date of the agreement to June 30, 2025.

On December 26, 2024, the Company filed with the Secretary of State of the State of Delaware an amendment to our amended and restated certificate of incorporation to change the date by which we must consummate a business combination to March 31, 2025 (subject to an additional three-month extension at the discretion of our Board).

On December 30, 2024, $14,335 was deposited into the Trust Account representing an Extension Payment. The Extension Payment was deposited from the Company’s operating account and is due from Sponsor.

<div align='center'>F-26</div>

TABLE OF CONTENTS

### REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the Stockholders and Board of Directors of 
 Iris Acquisition Corp (formerly known as Tribe Capital Growth Corp I)

### Opinion on the Financial Statements
We have audited the accompanying balance sheets of Iris Acquisition Corp (formerly known as Tribe Capital Growth Corp I) (the “Company”) as of December 31, 2023 and 2022, the related statements of operations